Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome
- PMID: 8580807
- DOI: 10.3109/10428199509056843
Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome
Abstract
A case is presented of a child with mosaic Down syndrome, who presented at birth with a transient leukemia and later progressed to megakaryoblastic leukemia. Evidence is presented that both leukemias were of megakaryoblastic lineage and evolved from a trisomic hematopoietic precursor. This case is unique in the poor course of the initial transient neonatal leukemia with improvement following chemotherapy. It also highlights the form of leukemia and associated myelodysplasia that occurs in children with Down syndrome. This form of leukemia and transient leukemia are interrelated and are unique to children with Down syndrome.
Similar articles
-
Megakaryoblastic leukemia and Down's syndrome: a review.Pediatr Hematol Oncol. 1987;4(3):211-30. doi: 10.3109/08880018709141272. Pediatr Hematol Oncol. 1987. PMID: 2978961 Review.
-
Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.Cancer Genet Cytogenet. 2009 Jan 1;188(1):54-6. doi: 10.1016/j.cancergencyto.2008.09.003. Cancer Genet Cytogenet. 2009. PMID: 19061782 No abstract available.
-
GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.Blood. 2003 Jun 1;101(11):4301-4. doi: 10.1182/blood-2003-01-0013. Epub 2003 Feb 13. Blood. 2003. PMID: 12586620
-
Acute megakaryoblastic leukemia in Down syndrome.Pediatr Blood Cancer. 2007 Dec;49(7 Suppl):1066-9. doi: 10.1002/pbc.21353. Pediatr Blood Cancer. 2007. PMID: 17943965 Review.
-
Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.Pediatr Blood Cancer. 2005 Jan;44(1):85-91. doi: 10.1002/pbc.20161. Pediatr Blood Cancer. 2005. PMID: 15390279 Review.
Cited by
-
Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.Int J Hematol. 2010 May;91(4):630-5. doi: 10.1007/s12185-010-0549-1. Epub 2010 Mar 18. Int J Hematol. 2010. PMID: 20237876
-
Hematopoietic disorders in Down syndrome.Int J Clin Exp Pathol. 2008 Jan 1;1(5):387-95. Int J Clin Exp Pathol. 2008. PMID: 18787621 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical